Mindfulness-based treatment for smoking cessation: a randomized controlled trial

Mindfulness-based treatment for smoking cessation: a randomized controlled trial

To evaluate the efficacy of a mindfulness-based treatment (MBT) for smoking cessation or reduction and compare it with that of cognitive behavioral therapy (CBT). This was a single-center randomized controlled clinical trial including 113 patients divided into two groups: MBT (n = 54) and CBT (n = 5...

Full description

Saved in:
Bibliographic Details
Published in:Jornal brasileiro de pneumologia Vol. 47; no. 6; p. e20210254
Main Authors: Araujo, Mariana Sponholz, Silva, Lucas Gabriel da, Pereira, Gabriel Monteiro Alves, Pinto, Nanci Ferreira, Costa, Fábio Marcelo, Moreira, Lucas, Nunes, Daniella Porfírio, Canan, Mariane Gonçalves Martynychen, Oliveira, Maria Helena Santos de
Format: Journal Article
Language:English
Published: Brazil Sociedade Brasileira de Pneumologia e Tisiologia 01-01-2021
Subjects:
Brazil
Cognitive Behavioral Therapy
Humans
Meditation
Mindfulness
Original
Psychotherapy, group
RESPIRATORY SYSTEM
Smoking Cessation
Tobacco Use Disorder
Treatment Outcome
Brazil
Atenção plena
Psicoterapia de grupo
Smoking cessation
Tobacco use disorder
Abandono do hábito de fumar
Meditação
Meditation
Cognitive behavioral therapy
Psychotherapy, group
Tabagismo
Mindfulness
Terapia cognitivo-comportamental
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To evaluate the efficacy of a mindfulness-based treatment (MBT) for smoking cessation or reduction and compare it with that of cognitive behavioral therapy (CBT). This was a single-center randomized controlled clinical trial including 113 patients divided into two groups: MBT (n = 54) and CBT (n = 59). The interventions comprised eight 90-min sessions. The primary outcome was smoking cessation at 16 weeks after program initiation. Secondary outcomes included reduction in the mean number of cigarettes smoked/day at 16 weeks after treatment initiation, as well as smoking cessation and reduction in the number of cigarettes smoked/day at the last program session. Participants had to attend ≥ 50% of the sessions to be included in the primary outcome analysis. An intention-to-treat analysis was also performed. There was no difference between the groups regarding the primary outcome (30.4% in the MBT group vs. 31.6% in the CBT group, p = 0.68) or immediate abstinence rates (47.8% in the MBT group vs. 36.8% in the CBT group, p = 0.47). Both treatments were equally effective in reducing the number of cigarettes smoked/day at the last program session (a reduction of 93.33% [0-100%] in the MBT group and of 70% [33.3-100%] in the CBT group, p = 0.92) and at 16 weeks after program initiation (a reduction of 57.1% [0-100%] in the MBT group and of 70% [25-100%] in the CBT group, p = 0.49). MBT appears to be as effective as CBT for smoking cessation or reduction and can be an option for the treatment of tobacco use disorders in Brazil (Brazilian Registry of Clinical Trials identifier: RBR-3w2scz [http://www.ensaiosclinicos.gov.br]).
Bibliography:CONFLICT OF INTEREST: None declared.
AUTHOR CONTRIBUTIONS: MSA, LGS, and GMAP: conception and planning of the study; interpretation of evidence; drafting and revision of preliminary and final versions; and approval of the final version. NFP: conception and planning of the study; drafting and revision of preliminary and final versions; and approval of the final version. FMC, LM, DPN, and MC: planning of the study; revision of the final version; and approval of the final version. MHSO: interpretation of evidence; revision of the final version; and approval of the final version.
ISSN:1806-3756
1806-3713
1806-3756
DOI:10.36416/1806-3756/e20210254